Search Within

Immunology Program Faculty

  1. "Peter Steinherz"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (10)
Groups
  1. Center for Hematologic Malignancies (33)
  2. Hematologic Malignancies Service (33)
  3. Pediatric Leukemia (33)
  4. Pediatrics, Department of (33)
  5. Sloan Kettering Institute Faculty (33)
  6. Department of Medicine (32)

More Groups

People
  1. Peter Steinherz (33)
  2. Richard O'Reilly (31)
  3. Nancy Kernan (22)
  4. Farid Boulad (18)
  5. Susan Prockop (15)
  6. Neerav Shukla (12)

More People

Years
  1. 2019 (1)
  2. 2017 (3)
  3. 2016 (1)
  4. 2015 (2)
  5. 2014 (5)
  6. 2013 (1)

More Years

Publications
  1. Blood (18)
  2. Biology of Blood and Marrow Transplantation (7)
  3. Pediatric Blood and Cancer (2)
  4. Clinical Cancer Research (1)
  5. International Journal of Infectious Diseases (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (7)
  3. American Association for Cancer Research (2)
  4. Wiley Periodicals, Inc (2)
  5. American Society of Clinical Oncology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Gulati, N.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jackson, C.; Kernan, N.; Kung, A. L.; O'Reilly, R.; Prockop, S.; Ramaswamy, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Myeloablative double-unit cord blood transplantation (CBT) in pediatric patients with high-risk acute leukemia demonstrates encouraging disease-free survival with both TBI and chemotherapy-only-based conditioning
    Meeting Abstract

    Scaradavou, A.; Lubin, M. N.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen for the treatment of pediatric relapsed B cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Kobos, R.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Renaud, T. M.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Prolonged hypogammaglobulinemia in pediatric lymphoma patients after rituximab therapy
    Meeting Abstract

    Terry, W.; Shukla, N.; Renaud, T.; Kernan, N.; Chaudhuri, J.; Steinherz, P.; Kobos, R.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save